Intercure (INCR) grants CFO 590,000 options expiring 2028

Rhea-AI Filing Summary

Intercure Ltd. (INCR) reported that its Chief Financial Officer, Cohen Amos, received a grant of 590,000 employee share options on June 9, 2026. These options relate to Ordinary Shares with an exercise price of $1.00 per share, based on a NIS 3.00 price converted at NIS 2.99 = $1.00. The options became fully vested on June 9, 2026 and expire on June 9, 2028. Following this grant, the reported derivative holdings from this award total 590,000 options held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cohen Amos

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee share options (right to buy) F1	590,000	$0.00	$0.00

Holdings After Transaction: Employee share options (right to buy) — 590,000 shares (Direct)

Footnotes (1)

1. F1. The options were granted on June 9, 2026, and the current exercise price is NIS 3.00 per share. For purposes of this Form 4, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.99 to USD $1.00 as of August 21, 2026, resulting in an exercise price of $1.00 per share. The options became fully vested as of June 9, 2026.

Key Figures

Employee share options granted: 590,000 options Exercise price (NIS): NIS 3.00 per share Exercise price (USD): $1.00 per share +3 more

6 metrics

Employee share options granted 590,000 options Grant to CFO Cohen Amos on June 9, 2026

Exercise price (NIS) NIS 3.00 per share Current exercise price stated in the footnote

Exercise price (USD) $1.00 per share Converted using NIS 2.99 to USD $1.00 as of August 21, 2026

Exchange rate NIS 2.99 to USD $1.00 Used to convert the option exercise price for Form 4

Expiration date June 9, 2028 Option expiration for the 590,000 granted options

Vesting date June 9, 2026 Options became fully vested as of this date

Key Terms

Employee share options (right to buy), exercise price, fully vested, exchange rate

4 terms

Employee share options (right to buy) financial

"security_title: "Employee share options (right to buy)""

exercise price financial

"The options were granted on June 9, 2026, and the current exercise price is NIS 3.00"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

fully vested financial

"The options became fully vested as of June 9, 2026."

exchange rate financial

"using an exchange rate of NIS 2.99 to USD $1.00 as of August 21, 2026"

Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.

FAQ

What insider transaction did INCR report for CFO Cohen Amos?

Intercure Ltd. reported that CFO Cohen Amos received a grant of 590,000 employee share options on June 9, 2026, relating to Ordinary Shares, with an exercise price of $1.00 per share and an expiration date of June 9, 2028.

What is the exercise price of the new options granted at Intercure Ltd. (INCR)?

The options have a current exercise price of NIS 3.00 per share, which, using an exchange rate of NIS 2.99 to USD $1.00 as of August 21, 2026, results in an exercise price of $1.00 per share for Form 4 reporting purposes.

How many Intercure Ltd. (INCR) options does the CFO hold from this grant after the transaction?

Following the reported transaction, CFO Cohen Amos holds 590,000 employee share options from this grant, all reported as held directly as of the transaction date.

When do the newly granted INCR options vest and expire?

The options granted to CFO Cohen Amos became fully vested on June 9, 2026, and are scheduled to expire on June 9, 2028, giving a two-year exercise period from the grant date.

Were the Intercure Ltd. (INCR) options granted to the CFO part of a purchase or a sale?

No purchase or sale was reported. The Form 4 describes the transaction as a grant or award acquisition of 590,000 employee share options, coded as transaction type A for a grant, not an open-market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/24/2026 - 04:06 PM Accepted by SEC EDGAR 08/24/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Amos

(Last) (First) (Middle)

85 MEDINAT HA-YEHUDIM STREET

(Street)

HERZLIYA 4676670

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Intercure Ltd. [ INCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee share options (right to buy)(1)	$1	06/09/2026		A		590,000		06/09/2026	06/09/2028	Ordinary Shares	590,000	$0	590,000	D

Explanation of Responses:

1. The options were granted on June 9, 2026, and the current exercise price is NIS 3.00 per share. For purposes of this Form 4, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.99 to USD $1.00 as of August 21, 2026, resulting in an exercise price of $1.00 per share. The options became fully vested as of June 9, 2026.

	/s/ Amos Cohen	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)